Filing Details
- Accession Number:
- 0001437749-21-021338
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-01 20:04:47
- Reporting Period:
- 2021-08-30
- Accepted Time:
- 2021-09-01 20:04:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
787253 | Natural Alternatives International Inc | NAII | Medicinal Chemicals & Botanical Products (2833) | 841007839 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1115556 | A Mark Ledoux | 1535 Faraday Avenue Carlsbad CA 92008 | Ceo/Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-08-30 | 2,500 | $15.68 | 161,212 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-09-01 | 2,500 | $16.22 | 158,712 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-30 | 2,500 | $15.65 | 484,405 | No | 4 | S | Indirect | By LeDoux Family Limited Partnership |
Common Stock | Disposition | 2021-09-01 | 2,500 | $16.21 | 481,905 | No | 4 | S | Indirect | By LeDoux Family Limited Partnership |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By LeDoux Family Limited Partnership |
No | 4 | S | Indirect | By LeDoux Family Limited Partnership |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 69,416 | Indirect | By IRA |
Common Stock | 7,200 | Indirect | By Self as Custodian for Marcelle Jeannette LeDoux |
Common Stock | 800 | Indirect | By Self as Custodian for Jean-Marc Emile LeDoux |
Common Stock | 6,000 | Indirect | By Self as Custodian for Aimee LeDoux |
Footnotes
- This transaction represents a sale pursuant to a Programmed Plan of Transactions Under Rule 10b5-1(c) of the Securities Exchange Act included as an Exhibit to Form 8-K filed with the SEC on March 26, 2021.
- Average sale price for sales between $15.50 and $15.95.
- Average sale price for sales between $16.20 and $16.30